A detailed history of Alps Advisors Inc transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 39,054 shares of MORF stock, worth $2.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,054
Previous 35,292 10.66%
Holding current value
$2.23 Million
Previous $1.24 Million 7.09%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$26.12 - $34.07 $98,263 - $128,171
3,762 Added 10.66%
39,054 $1.33 Million
Q1 2024

May 14, 2024

BUY
$26.64 - $40.31 $48,511 - $73,404
1,821 Added 5.44%
35,292 $1.24 Million
Q4 2023

Feb 14, 2024

SELL
$19.95 - $31.0 $37,366 - $58,063
-1,873 Reduced 5.3%
33,471 $966,000
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $48,739 - $135,774
2,285 Added 6.91%
35,344 $809,000
Q2 2023

Aug 14, 2023

BUY
$34.33 - $62.11 $1.13 Million - $2.05 Million
33,059 New
33,059 $1.9 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.